CIK 0000906709
- Non-accelerated filer
- Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943134940
- Phone
- +1 415-482-5300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-01-20 | Lingnau Lutz Director | Sale | −15,000 | $14.51 | $218K | 16,450 |
| 2016-01-20 | Lingnau Lutz Director | Exercise or conversion · Stock Option | −15,000 | 0 | ||
| 2016-01-19 | Thomsen Jillian B. SVP & Chief Accounting Officer | Exercise or conversion | +15,000 | $6.65 | $100K | 18,999 |
| 2016-01-19 | Thomsen Jillian B. SVP & Chief Accounting Officer | Sale | −15,000 | $14.12 | $212K | 3,999 |
| 2016-01-19 | Thomsen Jillian B. SVP & Chief Accounting Officer | Exercise or conversion · Stock Option | −15,000 | 30,000 | ||
| 2016-01-19 | ROBIN HOWARD W President & CEO | Exercise or conversion | +66,667 | $6.46 | $431K | 76,667 |
| 2016-01-19 | ROBIN HOWARD W President & CEO | Sale | −66,667 | $14.12 | $941K | 10,000 |
| 2016-01-19 | ROBIN HOWARD W President & CEO | Exercise or conversion · Stock Option | −66,667 | 66,666 |
Page 55 of 55 · 1,088 trades